ClinicalTrials.gov
ClinicalTrials.gov Menu

Asthma Patient Education in the Emergency Room

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00110409
Recruitment Status : Completed
First Posted : May 9, 2005
Last Update Posted : June 10, 2013
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
Hospital for Special Surgery, New York

Brief Summary:
The objective of this randomized trial is to assess the effectiveness of an intervention involving education, self-efficacy, and social support in improving quality of life outcomes among 296 adult asthma patients treated in the emergency room. The main outcome will be a comparison of within-patient change in quality of life between enrollment and 8 weeks. Secondary objectives will be to assess the effectiveness of the intervention in decreasing the need for rescue inhaled beta agonists, in improving peak flow meter rates, and in decreasing the number of days lost from work or school due to asthma. These outcomes will be measured again at 16 weeks to determine if benefits are sustained. Additional outcomes at 16 weeks and 1 year will be to assess the effectiveness of the intervention in decreasing urgent resource utilization for asthma and cost effectiveness.

Condition or disease Intervention/treatment Phase
Asthma Behavioral: Asthma Education in Adults Behavioral: Standard Emergency Room Asthma Education Not Applicable

Detailed Description:

BACKGROUND:

Many urban asthma emergency room patients lack effective self-management. Most current training programs are administered in outpatient settings and have low attendance rates for emergency room patients. There is a great need to develop effective programs that can be easily administered in the emergency room for patients who, in many cases, are not present in other settings to receive education. This proposal builds on preliminary studies and is tailored to provide emergency room patients with basic education during "a teachable moment" when they may be most receptive to asthma information.

DESIGN NARRATIVE:

Patients will be recruited from two New York City urban emergency rooms or inpatient settings and randomized to the intervention or control groups. Intervention patients will receive a protocol focusing on asthma self-management, education, self-efficacy, and social support, with telephone reinforcement for 8 weeks. Control patients will receive standard emergency room education about asthma.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 296 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Trial of Asthma Patient Education in the Emergency Room
Study Start Date : January 2005
Actual Primary Completion Date : February 2010
Actual Study Completion Date : February 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Intervention participants will receive information focusing on asthma self-management, education, self-efficacy, and social support while in the hospital emergency room. Telephone reinforcement will occur for 8 weeks following study entry.
Behavioral: Asthma Education in Adults
The intervention involves enhancing asthma education, asthma self-efficacy and asthma-related social support and is administered during a single in-person session in the ED (or hospital for admitted patients) followed by telephone reinforcement.
Active Comparator: 2
Participants in the control group will receive standard emergency room education about asthma.
Behavioral: Standard Emergency Room Asthma Education
Participants will receive standard emergency room education about asthma.



Primary Outcome Measures :
  1. Quality of life [ Time Frame: Measured at 8 weeks ]

Secondary Outcome Measures :
  1. Rescue inhaled beta agonist use [ Time Frame: Measured at 8 weeks ]
  2. Peak flow meter rates [ Time Frame: Measured at 8 weeks ]
  3. Number of days lost from work or school due to asthma [ Time Frame: Measured at 8 weeks ]
  4. Decreasing urgent resource utilization for asthma [ Time Frame: Measured at 16 weeks and 1 year ]
  5. Cost effectiveness [ Time Frame: Measured at 16 weeks and 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 95 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients will be eligible if they are 18 years of age or older
  • Fluent in English
  • Have a known diagnosis of asthma
  • Will receive treatment for asthma during the current hospitalization or emergency room visit.

Exclusion Criteria:

  • Cognitive deficits
  • Other pulmonary diseases or severe comorbidity
  • Do not have out-patient access to a telephone

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00110409


Locations
United States, New York
New York, New York, United States
Sponsors and Collaborators
Hospital for Special Surgery, New York
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Study Chair: Carol A. Mancuso, MD Hospital for Special Surgery, New York

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Carol A. Mancuso, MD, Hospital for Special Surgery
ClinicalTrials.gov Identifier: NCT00110409     History of Changes
Other Study ID Numbers: 173
R01HL075893 ( U.S. NIH Grant/Contract )
First Posted: May 9, 2005    Key Record Dates
Last Update Posted: June 10, 2013
Last Verified: June 2013

Additional relevant MeSH terms:
Asthma
Emergencies
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Disease Attributes
Pathologic Processes